Primary Site >> Liver Cancer
Gene >> ID2
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|
|
Ref: Expression of Id proteins in human hepatocellular carcinoma: relevance to tumor dedifferentiation. PMID: 15645115 |
Ref: Identification of ID2 associated with invasion of hepatitis C virus-related hepatocellular carcinoma by gene expression profile. PMID: 17088983 |
Ref: Decreased ID2 promotes metastatic potentials of hepatocellular carcinoma by altering secretion of vascular endothelial growth factor. PMID: 18281534 |
Ref: Epithelial-mesenchymal transition gene signature to predict clinical outcome of hepatocellular carcinoma. PMID: 20331628 |
Ref: [Damage effect of Polygonum multiflorum fractions on human normal liver cells L02 and liver cancer cells HepG2]. PMID: 22997834 |
Ref: Susceptibility of hepatoma-derived cells to histone deacetylase inhibitors is associated with ID2 expression. PMID: 23403953 Ref: Identification of FN1BP1 as a novel cell cycle regulator through modulating G1 checkpoint in human hepatocarcinoma Hep3B cells. PMID: 23469028 |
Ref: Hepatic inflammation facilitates transcription-associated mutagenesis via AID activity and enhances liver tumorigenesis. PMID: 25969143 |
Ref: EYA4 functions as tumor suppressor gene and prognostic marker in pancreatic ductal adenocarcinoma through beta-catenin/ID2 pathway. PMID: 27378242 |
Ref: BMP4 promotes metastasis of hepatocellular carcinoma by an induction of epithelial-mesenchymal transition via upregulating ID2. PMID: 28093286 Ref: BMP4 enhances hepatocellular carcinoma proliferation by promoting cell cycle progression via ID2/CDKN1B signaling. PMID: 28543546 |